코로나19임상시험포털

ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.

전체 2310건의 자료가 검색되었습니다.

코로나19(COVID19) 임상시험 현황
No.	Status	Study Title	Conditions	Interventions	Phase	Sponsor/Collaborators	Funder Type	Number Enrolled	Sex	Age	Locations
1540	Terminated	Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)	Covid19	Biological: ConvP Biological: FFP	Phase 3	Erasmus Medical Center, Prothya Biosolutions, ZonMw: The Netherlands Organisation for Health Research and Development, Leiden University Medical Center	OTHER	420	All	50 Years	Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands Meander Medisch Centrum, Amersfoort, Netherlands Rijnstate Ziekenhuis, Arnhem, Netherlands Amphia Ziekenhuis, Breda, Netherlands Groene Hart Ziekenhuis, Gouda, Netherlands University Medical Center Groningen (UMCG), Groningen, Netherlands Spaarne Gasthuis, Haarlem, Netherlands Medisch Centrum Leeuwarden, Leeuwarden, Netherlands Leids Universitair Medisch Centrum, Leiden, Netherlands Sint Antonius Ziekenhuis, Nieuwegein, Netherlands Bernhoven Hospital, Uden, Netherlands
1539	Recruiting	Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19	COVID-19	Biological: Current standard of care and COVID-19 convalescent and vaccinated plasma Other: Current standard of care	Phase 3	Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen, NHS Blood and Transplant	OTHER	680	All		CHU Besancon, Besancon, France Stauferklinikum Schwabisch Gmund, Mutlangen, Baden-Wuerttemberg, Germany Klinikum Stuttgart, Stuttgart, Baden-Wuerttemberg, Germany Diakonie-Klinikum Stuttgart, Stuttgart, Baden-Wuerttemberg, Germany Uniklinikum Tubingen, Tubingen, Baden-Wuerttemberg, Germany Institut fur Klinische Transfusionsmedizin (IKT), Ulm, Baden-Wuerttemberg, Germany Uniklinikum Ulm, Ulm, Baden-Wuerttemberg, Germany Universitatsklinikum Brandenburg, Brandenburg an der Havel, Brandenburg, Germany Universitatsklinikum Frankfurt, Frankfurt, Hessen, Germany Elblandkliniken Riesa, Riesa, Sachsen, Germany Charite Medizinische Klinik IV, Berlin, Germany Klinikum Chemnitz gGmbH, Chemnitz, Germany Erasmus Medical Center, Rotterdam, Netherlands NHS Blood and Transplant, Oxford, United Kingdom
1538	Completed	Early Intervention in COVID-19: Favipiravir Verses Standard Care	Coronavirus Infection	Drug: Favipiravir Other: Standard of care management	Phase 3	Chelsea and Westminster NHS Foundation Trust, NEAT ID Foundation, FUJIFILM Toyama Chemical Co., Ltd., Imperial College London	OTHER	502	All	18 Years	Grupo Hospitalar Conceicao, Porto Alegre, Brazil Fundacao Oswaldo Cruz - Instituto Nacional de Infectologia Evandro Chagas (Fiocruz/INI), Rio De Janeiro, Brazil Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran, Mexico City, Mexico Hull University Teaching Hospitals NHS Trust - Castle Hill Hospital, Hull, United Kingdom Chelsea and Westminster Hospital, London, United Kingdom West Middlesex University Hospital, London, United Kingdom
1537	Terminated	Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients	COVID-19	Drug: Enoxaparin	Phase 3	Thrombosis Research Institute, Sanofi	OTHER	219	All	55 Years	Harry Gibbs, National Co-ordinating Investigator, The Alfred Hospital, Melbourne, Australia Dr Frank Cools, National Co-ordinating Investigator, AZ Klina, Brasschaat, Belgium Prof. Barry Jacobson, National Coordinating Investigator, University of the Witwatersrand, Johannesburg, South Africa
1536	Completed	Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.	Coronavirus Disease 2019 )COVID-19)	Biological: COVID-19 Convalescent Plasma	Phase 3	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	OTHER	29	All	65 Years	Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, RM, Italy Ospedale SS Annunziata, Chieti, Italy Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Rome, Italy
1535	Completed	Early Treatment of Cytokine Storm Syndrome in Covid-19	COVID-19	Drug: Anakinra Drug: Normal saline	Phase 3	University of Alabama at Birmingham	OTHER	32	All	18 Years ~ 80 Years	University of Alabama at Birmingham, Birmingham, Alabama, United States
1534	Unknown status	Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2	Dexamethasone	Drug: Dexamethasone	Phase 3	Hospital Universitario Infanta Leonor	OTHER	200	All	18 Years